1st Quarter - Report

ML STRATEGIES, LLC for ASTELLAS PHARMA US, INC.

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$60,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report (this page) May 1, 2008 $60,000 Replaced
1st Quarter - Amendment Jan 6, 2010 $60,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

S. 2313 and H.R. 3697, The Strategies to Address Antimicrobial Resistance (STAAR Act); S. 2278, The Community and Healthcare Associated Infections (CHAI) Reduction Act; H. Res 988 and S. Res. 454 MRSA Awareness Month.

LobbyistCovered position, as disclosed
BRIAN CORRIGAN —
DAVID LEITER —
JEREMY RABINOVITZ Chief of Staff for Congresswoman Lois Capps

Bills named: S. 2278 (110th), H.Res. 988 (110th), S. 2313 (110th), H.R. 3697 (110th), S.Res. 454 (110th)

Medicare/Medicaid MMM

Issues related to the implementation of Section 501 (c) of the 2005 Deficit Reduction Act; S. 1951 and H.R. 3700, The Fair Medicaid Drug Payment Act, Section 2 (b) Prior Authorization Programs; S. 1887, and H.R. 3061 Amending Title XVIII of the Social Security Act to ensure access to critical medications under Medicare Part D.

LobbyistCovered position, as disclosed
BRIAN CORRIGAN —
DAVID LEITER —
JEREMY RABINOVITZ Chief of Staff for Congresswoman Lois Capps

Bills named: S. 1887 (110th), H.R. 3700 (110th), S. 1951 (110th), H.R. 3061 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.